论文部分内容阅读
新西兰人口320万,每年采血量为190 000单位,其中红细胞使用率为82%,白蛋白使用率为245kg/百万人/年,凝血因子Ⅷ1.82IU/人/年。新西兰所需的全部血液与血液制品完全自给自足。输血活动由输血咨询管理委员会来协调。新西兰的输血活动虽不由红十字会管理,但其目标始终是在免费为病人提供血液和血液制品方面实现完全自给自足。由于极注重质量控制,因此新西兰全国各地的输血机构一般都保持了高标准。目前新西兰所注意的3个方面是:协作、费用与对人的关心。 1、协作由于采用高成本技术,只有将输血活动实现高度的集中协作,才能最有效地利用血源。这样可避免重复购买昂贵的技术或设施,并有助于更好地控制成本。要建立一个全国性的输血机构,它应对经费有更全面的控制且成为事实上的执行者,否则,输血事业无法协调,费用也不能控制。
The population of New Zealand is 3.2 million. The annual blood volume is 190 000 units, of which the red blood cell utilization rate is 82%, the albumin use rate is 245 kg/million/year, and the coagulation factor VIII is 1.82 IU/person/year. All blood and blood products needed in New Zealand are completely self-sufficient. Blood transfusions are coordinated by the Transfusion Advisory Board. Although New Zealand’s blood transfusions are not managed by the Red Cross, the goal is always to be completely self-sufficient in providing patients with free blood and blood products. Due to the great emphasis on quality control, blood transfusion agencies throughout New Zealand generally maintain high standards. The three areas that New Zealand is currently paying attention to are: collaboration, cost, and care for people. 1. Collaboration Due to the use of high-cost technologies, blood sources can be most effectively utilized only if blood transfusion activities are highly centralized and coordinated. This avoids repeated purchases of expensive technology or facilities and helps to better control costs. To establish a nationwide blood transfusion agency, it should have more comprehensive control of the funds and be the de facto executor. Otherwise, the blood transfusion service cannot be coordinated and the cost cannot be controlled.